基于智能机器人的心血管内科住院患者健康教育体系构建及应用研究方案

注册号:

Registration number:

ChiCTR2400081504 

最近更新日期:

Date of Last Refreshed on:

2024-03-04 11:00:21 

注册时间:

Date of Registration:

2024-03-04 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于智能机器人的心血管内科住院患者健康教育体系构建及应用研究方案

Public title:

A research program on the construction and application of a health education system for cardiovascular medicine inpatients based on intelligent robots

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于智能机器人的心血管内科住院患者健康教育体系构建及应用研究方案

Scientific title:

A research program on the construction and application of a health education system for cardiovascular medicine inpatients based on intelligent robots

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

梅紫琦 

研究负责人:

张素菊 

Applicant:

Mei Ziqi 

Study leader:

Zhang Suju 

申请注册联系人电话:

Applicant telephone:

+86 134 7735 1924

研究负责人电话:

Study leader's
telephone:

+86 134 7735 1924

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

meiziqi77@163.com

研究负责人电子邮件:

Study leader's E-mail:

njucm065017549@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

江苏省南京市栖霞区仙林大道138号南京中医药大学护理学院

研究负责人通讯地址:

江苏省南京市栖霞区仙林大道138号南京中医药大学

Applicant address:

School of Nursing, Nanjing University of Traditional Chinese Medicine, No. 138 Xianlin Avenue, Qixia District, Nanjing, Jiangsu, China

Study leader's address:

Nanjing University of Traditional Chinese Medicine, No. 138 Xianlin Avenue, Qixia District, Nanjing, Jiangsu, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

南京中医药大学护理学院

Applicant's institution:

School of Nursing, Nanjing University of Chinese Medicine

研究负责人所在单位:

南京中医药大学第二附属医院江苏省第二中医院

Affiliation of the Leader:

School of Nursing, Nanjing University of Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2023SEZ-054-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

南京中医药大学第二附属医院江苏省第二中医院伦理委员会

Name of the ethic committee:

Ethics Committee of the Second Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, the Second Hospital of Traditional Chinese Medicine in Jiangsu Province, China

伦理委员会批准日期:

Date of approved by ethic committee:

2023-12-16 00:00:00

伦理委员会联系人:

曾智凤

Contact Name of the ethic committee:

Zeng Zhifeng

伦理委员会联系地址:

江苏省南京市汉中路155号江苏省中医院北院五号楼404室

Contact Address of the ethic committee:

Room 404, Building V, North Hospital, Jiangsu Provincial Hospital of Traditional Chinese Medicine, No. 155 Hanzhong Road, Nanjing, Jiangsu Province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 25 8656 0515

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

南京中医药大学

Primary sponsor:

Nanjing University of Chinese Medicine

研究实施负责(组长)单位地址:

江苏省南京市栖霞区仙林大道138号南京中医药大学

Primary sponsor's address:

Nanjing University of Traditional Chinese Medicine, No. 138 Xianlin Avenue, Qixia District, Nanjing, Jiangsu, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏省

市(区县):

Country:

China

Province:

Jiangsu

City:

单位(医院):

江苏省第二中医院

具体地址:

江苏省南京建邺区南湖路23号

Institution
hospital:

Jiangsu Second Hospital of Traditional Chinese Medicine

Address:

No. 23, Nanhu Road, Jianye District, Nanjing, Jiangsu Province, China

经费或物资来源:

Source(s) of funding:

none

研究疾病:

心血管疾病  

Target disease:

cardiovascular disease

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

单臂 

Study design:

Single arm 

研究目的:

本研究旨在探索智能机器人健康教育在临床护理过程中的临床适用性,您能够帮助我们明确智能机器人健康教育的应用需求、可行性以及可用性,为智能机器人健康教育的推广应用提供参考。  

Objectives of Study:

The purpose of this study is to explore the clinical applicability of intelligent robot health education in the process of clinical care, you can help us to clarify the application needs, feasibility, and usability of intelligent robot health education, and provide reference for the promotion and application of intelligent robot health education.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

纳排标准分护士和患者论述,护士排除标准:①外来进修、实习工作者;②调查期间未在岗的医护工作者,包括出差、学习、休假者。 主要由病区护士依据患者现阶段病情判断是否能够采用智能机器人健康教育,患者排除标准:①身体极度虚弱或处于急危重症状态;②不能理解量表、问卷者。

Exclusion criteria:

The exclusion criteria are discussed by nurses and patients. The exclusion criteria for nurses are: ① external training, internship workers; ② health care workers who are not on duty during the survey period, including those who are on business trips, studies, and vacations. The nurses in the ward judged whether the intelligent robots could be used for health education based on the current condition of the patients, and the patients were excluded from the criteria: ① extremely weak or in a state of acute and critical illness; ② those who could not understand the scales and questionnaires.

研究实施时间:

Study execute time:

From 2024-03-15 00:00:00 To 2024-12-16 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-03-15 00:00:00 To 2024-09-30 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

200

Group:

Observation Group

Sample size:

干预措施:

智能机器人健康教育

干预措施代码:

Intervention:

Intelligent Robotics for Health Education

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

江苏省 

市(区县):

 

Country:

China

Province:

Jiangsu

City:

单位(医院):

江苏省第二中医院 

单位级别:

三甲 

Institution
hospital:

Jiangsu Second Hospital of Traditional Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

护士版NASA任务负荷指数量表

指标类型:

主要指标

Outcome:

National Aeronautics and Space Administration Task Load Index,NASA-TLX

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

广泛性焦虑量表

指标类型:

次要指标

Outcome:

Generalized Anxiety Disorder Scale-7, GAD-7

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

none

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

none

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

none

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

质性研究数据采集与管理:在整个访谈过程中,使用录音笔和笔记对数据进行收集。在访谈结束后,24小时内录音被逐字转录,将资料导入NVivo 12.0软件,两名研究人员对收集的文字、资料等,反复进行提取与分析,通过小组讨论对意见进行整合,并同时整理被访者的人口学信息。 量性研究数据采集与管理:使用问卷星收集相关问卷数据,同时及时将资料信息导入SPSS软件,双人核对录入,保证数据记录及时、完整、准确、真实。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection and management of qualitative research: Throughout the interview process, data were collected using audio recorders and notes. At the end of the interviews, the recordings were transcribed verbatim within 24 hours, and the information was imported into the NVivo 12.0 software. The two researchers repeatedly extracted and analyzed the collected text and information, integrated the opinions through group discussions, and simultaneously organized the demographic information of the interviewees. Quantitative research data collection and management: use questionnaire star to collect relevant questionnaire data, at the same time timely data information imported into the SPSS software, double checking entry, to ensure that the data records are timely, complete, accurate and true.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2024-03-04 10:59:50